Recent Updates
Recently added Catalysts
RIGL Positive Sentiment

Rigel to Present at the Jefferies Global Healthcare Conference

Wednesday, May 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rigel Pharmaceuticals, Inc. will present an overview at the Jefferies Global Healthcare Conference on June 3, 2026. CEO Raul Rodriguez will lead the presentation, showcasing the company's focus on hematologic disorders and cancer. Interested parties can access the live webcast through Rigel's website.
Price reaction · baseline $29.17 (2026-05-26 close) · hit after-hours · clean, no other RIGL news in the window
day 0 close · peak
+1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals is actively engaging in investor relations.
  • The presentation at a notable conference highlights Rigel's commitment to transparency.
  • The company's focus on hematologic disorders and cancer is crucial for patient care.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+72%
120-day peak, hindsight
Typical move
12.7%
average across 7 past catalysts
Lead asset
Fostamatinib
Phase 2 · Acute Respiratory Distress Syndrome

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.,May 27, 2026/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 8:45 a.m. ET in New York, NY.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website atwww.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About RigelRigel Pharmaceuticals, Inc. (Nasdaq:RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visitwww.rigel.com.

Contact for Investors & Media:Investors:Rigel Pharmaceuticals, Inc.650.624.1232[email protected]

Media:David RosenArgot Partners646.461.6387[email protected]

Frequently Asked Questions

When will Rigel present at the Jefferies Conference?

Rigel will present on June 3, 2026, at 8:45 a.m. ET.

Who is presenting for Rigel Pharmaceuticals?

Raul Rodriguez, the president and CEO, will present the company overview.

How can I access the presentation?

The presentation can be accessed via the Investor Relations section on Rigel's website.

What is Rigel Pharmaceuticals focused on?

Rigel focuses on developing therapies for hematologic disorders and cancer.

ShareAdd on Google
Tags: RIGL Rigel Pharmaceuticals Jefferies Conference healthcare biotechnology
Last updated: May 27, 2026

Biotech snapshot

Cash runway
$95M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FostamatinibPhase 2
Acute Respiratory Distress Syndrome →

Catalyst track record

+72%
best trade around RIGL's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for RIGL.

See every catalyst's timing & PoA →